While 2015 was a record year for mergers and acquisitions in France, 2016 slowed down and results were postponed for the first three quarters of the year. Major deals, involving French companies, failed in 2016. In the telecoms sector, Altice failed to acquire SFR while in pharmaceuticals, Sanofi was surpassed by Pfizer in the acquisition of Medivation (these deals alone represented a total value of €15bn).
